BackBellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) Overview

Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) Profit Margin

Latest profit margin for Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ): 787.47% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-363.79%
↑ 28.52% YoY

As of Sep 2026

Annual Profit Margin (TTM)

787.47%
↑ 191.05% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) (BLACU) FAQ

Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right )'s profit margin stands at 787.47% as of September 2026. That compares with -864.92% in the prior-year period — up 191.0% year over year. That is above the sector sector average of 13.4%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) reported 787.47% in profit margin versus -864.92% a year earlier — a 191.0% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) sits higher the its sector benchmark (13.4%) with a profit margin of 787.47%. That is roughly 5775.1% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 787.47% for Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right )'s profit margin evolved across reporting periods, while the comparison chart places BLACU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.